Transcriptome levels of TGF-β1, TNF-α, and IL-1B, the known molecules related to potential PFD-acting mechanisms, were evaluated, and no significant differences were observed between those before and after PFD administration (Supplementary Table S7). This evidence concerns the gene TNF and polyostotic fibrous dysplasia.